Company record
AgonOx, Inc. develops immunotherapy agents and cancer therapeutics, offering a portfolio that spans recombinant proteins, antibodies, agonists, small‑molecule compounds, and other immune system activators.
This directory record does not yet have a linked material-flow brief.